Skip to main content

GOLDMAN SACHS GROUP INC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in CRNX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,814,588
-$3,585,172 QoQ
Shares Held
628,155
+10.8% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 99.92740645222915.ToString("F0")% Shared 0.ToString("F0")% None 0.07259354777085274.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. CRNX ranks #91 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,814,588 628,155
2025-12-31 $26,399,760 567,127
2025-09-30 $29,701,863 713,130
2025-06-30 $25,909,509 900,887
2025-03-31 $16,756,382 499,594
2024-12-31 $36,878,483 721,269
2024-09-30 $40,217,130 787,028
2024-06-30 $29,077,219 649,190
2024-03-31 $40,448,848 864,107
2023-12-31 $23,133,155 650,173
2023-09-30 $16,434,263 552,598
2023-06-30 $11,079,524 614,846
2023-03-31 $8,354,379 520,198
2022-12-31 $2,439,682 133,316
2022-09-30 $2,409,198 122,668
2022-06-30 $1,817,498 97,453
2022-03-31 $2,427,735 110,603
2021-12-31 $1,747,782 61,520
2021-09-30 $1,166,695 55,425
2021-06-30 $1,146,173 60,805
2021-03-31 $1,869,538 122,352
2020-12-31 $1,808,648 128,182
2020-09-30 $1,588,812 101,392
2020-06-30 $246,033 14,043